Untested Stem Cell Treatments: An Analysis of Australia's Current Regulatory Regime

Nicolas Cavasinni, Patrick Foong

Research output: Contribution to journalArticlepeer-review

Abstract

Stem cell therapies have emerged as a miracle cure that could treat diseases and conditions. The past decade has seen the rapid growth of private clinics in some nations, including Australia, offering stem cell treatments largely untested and unsupported by clinical trials. These putative treatments have caused adverse events, some of which were serious and even fatal. The unscrupulous businesses exploit vulnerable and desperate patients who falsely believe these unproven therapies are their only salvation to cure different illnesses and conditions. This article emphasises the importance of strict oversight to ensure that only safe stem cell products reach patients, given the largely vulnerable patient base and the magnitude of risks involved. It examines the effectiveness of Australia's regulatory environment governing stem cell therapies to restrict the advertisement of dangerous and unproven stem cell therapies and the enforceability of these measures.

Original languageEnglish
Pages (from-to)105-121
Number of pages17
JournalJournal of Law and Medicine
Volume31
Issue number1
Publication statusPublished - 1 May 2024

Keywords

  • exploitation
  • risks
  • stem cell therapies
  • vulnerability

Fingerprint

Dive into the research topics of 'Untested Stem Cell Treatments: An Analysis of Australia's Current Regulatory Regime'. Together they form a unique fingerprint.

Cite this